• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存分析中评估预后因素时的样本量考量

Sample size considerations for the evaluation of prognostic factors in survival analysis.

作者信息

Schmoor C, Sauerbrei W, Schumacher M

机构信息

Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan-Meier-Str. 26, D-79104 Freiburg, Germany.

出版信息

Stat Med. 2000 Feb 29;19(4):441-52. doi: 10.1002/(sici)1097-0258(20000229)19:4<441::aid-sim349>3.0.co;2-n.

DOI:10.1002/(sici)1097-0258(20000229)19:4<441::aid-sim349>3.0.co;2-n
PMID:10694729
Abstract

When the role of a new prognostic factor is investigated, careful planning of an appropriate study is required. This includes an assessment of the power of the study in terms of sample sizes. An adequate analysis of the independent prognostic effect of a new factor has to be adjusted for the existing standard factors. With survival time as endpoint this will usually be done with the Cox proportional hazards model. Sample size and power formulae in survival analysis have been developed by Schoenfeld for randomized treatment comparisons. In the analysis of prognostic factors the covariates included are expected to be correlated with the factor of primary interest. In this situation, the existing sample size and power formulae are not valid and may not be applied. In this paper, Schoenfeld's formula is first extended to the situation where a correlated factor is included in the analysis. The validity of the resulting approximate asymptotic formula is investigated for its asymptotic behaviour by numerical integration and for its finite behaviour by simulation. Second, an approximate formula for sample size and power is provided to detect an interaction between the interesting and a second correlated factor. This extends the formula for independent effects. Finally, the approach is illustrated by an example on the prognostic impact of DNA ploidy and other factors in advanced ovarian cancer.

摘要

在研究新的预后因素的作用时,需要对适当的研究进行精心规划。这包括根据样本量评估研究的效能。对新因素的独立预后效应进行充分分析时,必须对现有的标准因素进行校正。以生存时间作为终点,这通常使用Cox比例风险模型来完成。Schoenfeld已针对随机治疗比较开发了生存分析中的样本量和效能公式。在预后因素分析中,纳入的协变量预计与主要关注的因素相关。在这种情况下,现有的样本量和效能公式无效,可能无法应用。在本文中,Schoenfeld公式首先扩展到分析中包含相关因素的情况。通过数值积分研究所得近似渐近公式的渐近行为,并通过模拟研究其有限行为来检验其有效性。其次,提供了一个用于样本量和效能的近似公式,以检测感兴趣的因素与第二个相关因素之间的相互作用。这扩展了独立效应的公式。最后,通过一个关于DNA倍体和其他因素对晚期卵巢癌预后影响的例子来说明该方法。

相似文献

1
Sample size considerations for the evaluation of prognostic factors in survival analysis.生存分析中评估预后因素时的样本量考量
Stat Med. 2000 Feb 29;19(4):441-52. doi: 10.1002/(sici)1097-0258(20000229)19:4<441::aid-sim349>3.0.co;2-n.
2
Sample size formula for proportional hazards modelling of competing risks.用于竞争风险比例风险建模的样本量公式。
Stat Med. 2004 Nov 15;23(21):3263-74. doi: 10.1002/sim.1915.
3
Sample size determination for comparing more than two survival distributions.比较两个以上生存分布时的样本量确定
Stat Med. 1995 Oct 30;14(20):2273-82. doi: 10.1002/sim.4780142010.
4
Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.具有事件发生时间终点的分层临床试验中的异质性治疗效果。
Biom J. 2017 May;59(3):511-530. doi: 10.1002/bimj.201600047. Epub 2017 Mar 6.
5
Prognostic significance of DNA content in epithelial ovarian cancer.DNA含量在上皮性卵巢癌中的预后意义。
Gynecol Oncol. 1994 Apr;53(1):5-12. doi: 10.1006/gyno.1994.1078.
6
Sample size determination for comparing several survival curves with unequal allocations.用于比较几个不等分配的生存曲线的样本量确定。
Stat Med. 2004 Jun 15;23(11):1793-815. doi: 10.1002/sim.1771.
7
Sample sizes for clinical trials with time-to-event endpoints and competing risks.具有事件发生时间终点和竞争风险的临床试验的样本量。
Contemp Clin Trials. 2005 Jun;26(3):386-96. doi: 10.1016/j.cct.2005.01.010. Epub 2005 Apr 26.
8
Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.评估脱氧核糖核酸倍体和S期分数作为晚期上皮性卵巢癌的预后参数:一项前瞻性研究。
Am J Obstet Gynecol. 1994 Feb;170(2):479-87. doi: 10.1016/s0002-9378(94)70215-2.
9
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.乳腺癌中DNA倍体和细胞增殖的短期意义:对308例患者预后标志物的多变量分析
J Clin Pathol. 1999 Aug;52(8):604-11. doi: 10.1136/jcp.52.8.604.
10
Comparing sample size formulae for trials with unbalanced allocation using the logrank test.比较使用对数秩检验的非平衡分配试验的样本量公式。
Stat Med. 1992 Jun 15;11(8):1091-8. doi: 10.1002/sim.4780110810.

引用本文的文献

1
Design aspects for prognostic factor studies.预后因素研究的设计方面。
BMJ Open. 2025 Aug 31;15(8):e095065. doi: 10.1136/bmjopen-2024-095065.
2
Prognostic factors associated with failure of total elbow replacement: a protocol for analysis of National Joint Registry data in England.与全肘关节置换失败相关的预后因素:英格兰国家关节注册数据的分析方案
BMJ Open. 2025 Jul 1;15(7):e098729. doi: 10.1136/bmjopen-2025-098729.
3
Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration.
肾功能受损患者复发性中风风险增加:来自MICON国际合作项目个体患者数据的汇总分析结果
J Neurol Neurosurg Psychiatry. 2025 Apr 24. doi: 10.1136/jnnp-2024-335110.
4
Prognostic value of interictal epileptiform discharges on routine EEG in adults with epilepsy.成人癫痫患者常规脑电图发作间期癫痫样放电的预后价值
Epilepsia. 2025 Jun;66(6):2079-2088. doi: 10.1111/epi.18318. Epub 2025 Mar 12.
5
Predictors of outcome in sciatica patients following an epidural steroid injection: the POiSE prospective observational cohort study protocol.经皮类固醇注射治疗坐骨神经痛患者结局的预测因素:POiSE 前瞻性观察队列研究方案。
BMJ Open. 2023 Nov 19;13(11):e077776. doi: 10.1136/bmjopen-2023-077776.
6
Injury Patterns and Incidence in an Elite Youth Football Academy-A Prospective Cohort Study of 138 Male Athletes.精英青少年足球学院的损伤模式与发生率——一项对138名男性运动员的前瞻性队列研究
J Clin Med. 2023 Sep 22;12(19):6138. doi: 10.3390/jcm12196138.
7
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.哪些转移性激素敏感性前列腺癌患者从多西他赛治疗中获益:来自随机试验的个体参与者数据的系统评价和荟萃分析。
Lancet Oncol. 2023 Jul;24(7):783-797. doi: 10.1016/S1470-2045(23)00230-9.
8
Joint inference of physiological network and survival analysis identifies factors associated with aging rate.联合推断生理网络和生存分析确定与衰老速度相关的因素。
Cell Rep Methods. 2022 Dec 2;2(12):100356. doi: 10.1016/j.crmeth.2022.100356. eCollection 2022 Dec 19.
9
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.18q11.2-q12.1 染色体缺失对转移性结直肠癌贝伐珠单抗获益的预测价值:AGITG-MAX 随机 III 期试验的事后分析。
Int J Cancer. 2022 Oct 1;151(7):1166-1174. doi: 10.1002/ijc.34061. Epub 2022 May 23.
10
Real-world data from selective laser trabeculoplasty in Brazil.巴西选择性激光小梁成形术的真实世界数据。
Sci Rep. 2022 Feb 4;12(1):1923. doi: 10.1038/s41598-022-05699-6.